Microglia In Chronic Neuroinflammation is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Microglia in Chronic Neuroinflammation represent a sustained, maladaptive activation state of brain immune cells that contributes to neurodegeneration. Unlike acute beneficial inflammation, chronic microglial activation drives progressive neuronal dysfunction and cell death.
Chronic neuroinflammation is a hallmark of virtually all neurodegenerative diseases, with microglia as the primary cellular mediators of this persistent inflammatory state.
- Ameboid shape: In severe activation
- Hypertrophic soma: Enlarged cell body
- Retracted processes: Reduced surveillance
- Plaque association: Clustering around pathology
- Pro-inflammatory cytokines: IL-1β, IL-6, TNF-α
- Nitric oxide (NO): Via iNOS
- Reactive oxygen species (ROS): Superoxide, peroxynitrite
- Chemoattractants: CCL2, CXCL10
- TNF-α: Induces apoptosis, disrupts BBB
- IL-1β: Impairs neurogenesis, promotes tau pathology
- IL-6: Disrupts synaptic plasticity
- NADPH oxidase activation: ROS burst
- Mitochondrial dysfunction: Energy failure
- Lipid peroxidation: Membrane damage
- DNA damage: Genomic instability
- Glutamate release: Anion channels
- Impaired uptake: Astrocyte dysfunction
- Calcium dysregulation: Overactivation
- Amyloid-induced: Aβ activates microglia
- Chronic activation: Years before symptoms
- Tau progression: Microglial spread
- NLRP3 inflammasome: Key driver
- SNc vulnerability: High microglial density
- α-Synuclein recognition: TLR-dependent
- Dopaminergic toxicity: Inflammatory milieu
- Progression: Linked to severity
- Motor neuron loss: Microglia-mediated
- SOD1 mutations: Cell-autonomous activation
- Perpetual inflammation: Feed-forward loop
- Demyelination: Phagocytic attack
- Lesion formation: Inflammatory cascades
- Chronic progression: Microglial scars
- Minocycline: Microglial inhibitor
- TNF inhibitors: Blocking cytokines
- NLRP3 inhibitors: Inflammasome blockade
- CSF1R antagonists: Reduce microglial numbers
- TREM2 modulation: Fine-tune activation
- PPAR agonists: Shift phenotype
- BDNF delivery: Counteract toxicity
- Antioxidants: Reduce oxidative stress
- Microglial replacement: Emerging therapy
- IL-6: Serum/CSF
- TNF-α: CSF levels
- YKL-40: Chitinase-3-like protein
- TSPO PET: Microglial activation
- MR spectroscopy: Inflammatory metabolites
The study of Microglia In Chronic Neuroinflammation has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Heneka MT, et al. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology.
- Block ML, et al. (2007). Microglia-mediated neurotoxicity. Nature Reviews Neuroscience.
- Perry VH, et al. (2010). Microglia in the degenerating brain. Neuropathology and Applied Neurobiology.